The Thrombectomy Devices Market size in the Middle East & Africa was worth USD 0.11 billion in 2021. It is expected to reach USD 0.14 billion by 2026, growing at a CAGR of 5.49% from 2021 to 2026.
Thrombectomy Devices can be defined as emergency removal of thrombi by surgical procedures, leading to blocked blood circulation. Thrombi are actually blood clots, but in common usage, it can refer to any material that blocks blood flow and can lead to health problems. Generally, the last resort as a hindrance of blood flow to organs for a long time can lead to necrosis.
Generally, the most used surgical procedures are surgical embolectomy, balloon embolectomy, and aspiration embolectomy. Surgical embolectomy clot removal by surgical incision into an artery. Aspiration embolectomy involves thrombus removal by using suction instead of a balloon. It is considered an effective way for thrombi removal in limb arteries. In balloon embolectomy, the catheter is inserted into a blood vessel, which has an inflatable balloon at the tip, inflated after its insertion into a clot. Then the balloon is removed along with the clot. This procedure involves risk since there is a chance of intimal lesions, giving rise to another thrombosis.
The driving factors of the Middle East and Africa Thrombectomy Devices market are increasing demand for minimally invasive procedures, technological innovations in the medical field, growing geriatric population, rising prevalence of cardiovascular diseases, and growing sedentary lifestyle. However, the market is constrained by factors like lack of awareness about peripheral vascular diseases, difficulty using new equipment, and lack of skilled workers.
This research report on the Middle East and Africa Thrombectomy Devices Market has been segmented and sub-segmented into the following categories:
By Type:
By Application:
By End Users:
By Disease:
By Country:
Geographically, the market is still in its nascent stages in the region. Factors such as rising technological innovations in the medical field, rising geriatric population, and increased incidence of cardiovascular diseases are expected to drive the market growth in the region.
Companies operating in the MEA Thrombectomy Devices Market Profiled in the Report are Stryker Corporation (U.S.), Medtronic Plc (U.S.), Boston Scientific Corporation (U.S.), Penumbra, Inc. (U.S.) Johnson & Johnson (U.S.), Terumo Corporation (Japan), Spectranetics Corporation (U.S.), Edwards Lifesciences Corporation (U.S.), Argon Medical Devices, Inc. (U.S.), and Teleflex Incorporated (U.S.).
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Type
5.1.1 Stent Retrievers
5.1.2 Basket/Brush Retrievers
5.1.3 Coil Retrievers
5.1.4 Mechanical Thrombectomy Devices
5.1.4.1 Stent Retrievers
5.1.4.2 Coil Retrievers
5.1.4.3 Basket/Brush Retrievers
5.1.5 Ultrasonic Thrombectomy Devices
5.1.6 Aspiration Thrombectomy Devices
5.1.7 Hydrodynamic Thrombectomy Devices
5.1.8 Y-o-Y Growth Analysis, By Type
5.1.9 Market Attractiveness Analysis, By Type
5.1.10 Market Share Analysis, By Type
5.2 Application
5.2.1 Peripheral Vascular Application
5.2.2 Neurovascular Application
5.2.3 Cardiovascular Application
5.2.4 Y-o-Y Growth Analysis, By Application
5.2.5 Market Attractiveness Analysis, By Application
5.2.6 Market Share Analysis, By Application
5.3 End-Users
5.3.1 Research Laboratories & Academic Institutes
5.3.2 Ambulatory Surgical Centres
5.3.3 Hospital Surgical Centres
5.3.4 Other end-users
5.3.5 Y-o-Y Growth Analysis, By End-Users
5.3.6 Market Attractiveness Analysis, By End-Users
5.3.7 Market Share Analysis, By End-Users
5.4 Diseases
5.4.1 Coronary Diseases
5.4.2 Neural Diseases
5.4.3 Peripheral Diseases
5.4.4 Y-o-Y Growth Analysis, By Diseases
5.4.5 Market Attractiveness Analysis, By Diseases
5.4.6 Market Share Analysis, By Diseases
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Type
6.1.3.2 By Application
6.1.3.3 By End-Users
6.1.3.4 By Diseases
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Type
6.1.4.2 By Application
6.1.4.3 By End-Users
6.1.4.4 By Diseases
6.1.5 Market Share Analysis
6.1.5.1 By Type
6.1.5.2 By Application
6.1.5.3 By End-Users
6.1.5.4 By Diseases
6.2 Middle-East
6.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Stryker Corporation
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Medtronic Plc
8.3 Boston Scientific Corporation
8.4 Penumbra, Inc.
8.5 Johnson & Johnson
8.6 Terumo Corporation
8.7 Spectranetics Corporation
8.8 Edwards Lifesciences Corporation
8.9 Argon Medical Devices, Inc.
8.10 Teleflex Incorporated
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
